Prognostic factors in chronic lymphocytic leukemia-what do we need to know?
- PMID: 20956983
- DOI: 10.1038/nrclinonc.2010.167
Prognostic factors in chronic lymphocytic leukemia-what do we need to know?
Abstract
Of all leukemias, chronic lymphocytic leukemia (CLL) shows the highest variability in its clinical presentation and course. CLL can present as an aggressive and life threatening leukemia or as an indolent form that will not require treatment over decades. The currently available clinical staging systems for CLL are simple and inexpensive but lack accuracy to predict disease progression and survival on an individual basis. The increased understanding of the key events of molecular pathogenesis has provided a plethora of novel molecular and biological factors that correlate with the outcome of CLL. This Review provides a concise discussion of the most important discoveries and gives guidance on how to implement novel prognostic tools in the clinical management of CLL by applying the criteria of evidence, relevance, and simplicity to the selection of prognostic markers.
Similar articles
-
Chronic lymphocytic leukemia: prognostic factors and impact on treatment.Discov Med. 2011 Feb;11(57):115-23. Discov Med. 2011. PMID: 21356166 Review.
-
Prognostication of chronic lymphocytic leukemia in the era of new agents.Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):149-155. doi: 10.1182/asheducation-2016.1.149. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913474 Free PMC article. Review.
-
Incorporating molecular biomarkers into the continuum of care in chronic lymphocytic leukemia.Leuk Lymphoma. 2021 Jun;62(6):1289-1301. doi: 10.1080/10428194.2020.1869966. Epub 2021 Jan 7. Leuk Lymphoma. 2021. PMID: 33410372 Review.
-
Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.JAMA Oncol. 2015 Oct;1(7):965-74. doi: 10.1001/jamaoncol.2015.0779. JAMA Oncol. 2015. PMID: 26181643 Review.
-
Genomic Features: Impact on Pathogenesis and Treatment of Chronic Lymphocytic Leukemia.Oncol Res Treat. 2016;39(1-2):34-40. doi: 10.1159/000443906. Epub 2016 Jan 26. Oncol Res Treat. 2016. PMID: 26890126 Review.
Cited by
-
Chronic lymphocytic leukemia-associated chromosomal abnormalities and miRNA deregulation.Appl Clin Genet. 2012 Mar 12;5:21-8. doi: 10.2147/TACG.S18669. Print 2012. Appl Clin Genet. 2012. PMID: 23776377 Free PMC article.
-
Prognostic factors in CLL.Leuk Suppl. 2012 Aug;1(Suppl 2):S29-30. doi: 10.1038/leusup.2012.17. Epub 2012 Aug 9. Leuk Suppl. 2012. PMID: 27175240 Free PMC article.
-
Targeting CD38 in Neoplasms and Non-Cancer Diseases.Cancers (Basel). 2022 Aug 28;14(17):4169. doi: 10.3390/cancers14174169. Cancers (Basel). 2022. PMID: 36077708 Free PMC article. Review.
-
Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL).Diagnostics (Basel). 2021 Nov 4;11(11):2041. doi: 10.3390/diagnostics11112041. Diagnostics (Basel). 2021. PMID: 34829391 Free PMC article.
-
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.Blood. 2014 Jul 3;124(1):49-62. doi: 10.1182/blood-2014-02-556399. Epub 2014 May 5. Blood. 2014. PMID: 24797299 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources